The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib®)
Andreas Gäumann(University of Regensburg), Georg Breier(University Hospital Carl Gustav Carus), Hannes C. A. Drexler(Max Planck Institute for Molecular Biomedicine), Guido Bold(Novartis (Switzerland)), Elisabeth Buchdunger(Novartis (Switzerland)), Sven A. Lang(Essen University Hospital), Oliver Stoeltzing(The University of Texas MD Anderson Cancer Center), Jeanette M. Wood(Novartis (Switzerland)), Simone Diermeier‐Daucher(Zero to Three)
Cited by 14
Related Papers
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
|Nature|1996|4.2k
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
|Nature|1992|2.3k
Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
|Development|1992|1.1k
The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities
|Journal of Biological Chemistry|1996|845
Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes.
|Journal of Biological Chemistry|1995|765